Vault-13

Sands Capital Alternatives, LLC

ARLINGTON, VA · CIK 1846444 · 13F filing filed 2025-08-13

SEC-registered investment adviser since 2011 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Arlington, VA (main office)United States United Statesabout 60
Fitzrovia LondonUnited Kingdom United Kingdom2
San Francisco, CAUnited States United States2
New York City, NYUnited States United States1
San Juan, PRUnited States United States1
SingaporeSingapore Singapore

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$507.8m reported value +24.2% vs Q1 2025
19positions
92.3%in top 10
0 new 10 added 1 reduced 1 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 KLAVIYO INC COM SER A KVYO KVYO 3,515,065 $118.0m23.24% 23.24% AddedShares held: Q3 2024 3.5m, Q4 2024 3.5m, Q1 2025 3.4m, Q2 2025 3.5m +71.5k +71,550 2.1%
2 NU HLDGS LTD ORD SHS CL A NU NU 7,175,434 $98.4m19.39% 19.39% AddedShares held: Q3 2024 5.5m, Q4 2024 7.0m, Q1 2025 7.2m, Q2 2025 7.2m +11.1k +11,079 0.1%
3 DOORDASH INC CL A DASH DASH 381,202 $94.0m18.50% 18.50% AddedShares held: Q3 2024 423.3k, Q4 2024 407.3k, Q1 2025 380.7k, Q2 2025 381.2k +498 +498 0.1%
4 BETA BIONICS INC COM BBNX BBNX 3,570,113 $52.0m10.24% 10.24% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 3.1m, Q2 2025 3.6m +466.3k +466,331 15.0%
5 COUPANG INC CL A CPNG CPNG 849,031 $25.4m5.01% 5.01% AddedShares held: Q3 2024 11.9k, Q4 2024 924.7k, Q1 2025 843.5k, Q2 2025 849.0k +5.6k +5,555 0.7%
6 INHIBIKASE THERAPEUTICS INC COM NEW IKT IKT 10,950,000 $21.4m4.20% 4.20% UnchangedShares held: Q3 2024 0, Q4 2024 10.9m, Q1 2025 10.9m, Q2 2025 10.9m
7 MONDAY COM LTD SHS MNDY MNDY 58,336 $18.3m3.61% 3.61% AddedShares held: Q3 2024 0, Q4 2024 48.3k, Q1 2025 49.9k, Q2 2025 58.3k +8.4k +8,428 16.9%
8 SAMSARA INC COM CL A IOT IOT 438,485 $17.4m3.43% 3.43% AddedShares held: Q3 2024 3.2k, Q4 2024 198.7k, Q1 2025 253.4k, Q2 2025 438.5k +185.1k +185,053 73.0%
9 DATADOG INC CL A COM DDOG DDOG 118,707 $15.9m3.14% 3.14% AddedShares held: Q3 2024 1.4k, Q4 2024 97.8k, Q1 2025 117.9k, Q2 2025 118.7k +777 +777 0.7%
10 CROWDSTRIKE HLDGS INC CL A CRWD CRWD 15,615 $8.0m1.57% 1.57% AddedShares held: Q3 2024 221, Q4 2024 17.1k, Q1 2025 15.6k, Q2 2025 15.6k +55 +55 0.3%
11 TOAST INC CL A TOST TOST 156,604 $6.9m1.37% 1.37% ReducedShares held: Q3 2024 4.5k, Q4 2024 231.5k, Q1 2025 210.6k, Q2 2025 156.6k -54.0k -54,007 -25.6%
12 TARSUS PHARMACEUTICALS INC COM TARS TARS 170,000 $6.9m1.36% 1.36% UnchangedShares held: Q3 2024 170.0k, Q4 2024 170.0k, Q1 2025 170.0k, Q2 2025 170.0k
13 SNOWFLAKE INC CL A SNOW SNOW 27,005 $6.0m1.19% 1.19% AddedShares held: Q3 2024 108.3k, Q4 2024 39.0k, Q1 2025 26.8k, Q2 2025 27.0k +177 +177 0.7%
14 10X GENOMICS INC CL A COM TXG TXG 481,770 $5.6m1.10% 1.10% UnchangedShares held: Q3 2024 481.8k, Q4 2024 481.8k, Q1 2025 481.8k, Q2 2025 481.8k
15 ACUMEN PHARMACEUTICALS INC COM ABOS ABOS 3,417,075 $4.0m0.78% 0.78% UnchangedShares held: Q3 2024 3.4m, Q4 2024 3.4m, Q1 2025 3.4m, Q2 2025 3.4m
16 BIOAGE LABS INC COM BIOA BIOA 786,353 $3.2m0.64% 0.64% UnchangedShares held: Q3 2024 1.1m, Q4 2024 786.4k, Q1 2025 786.4k, Q2 2025 786.4k
17 ACRIVON THERAPEUTICS INC COMMON STOCK ACRV ACRV 2,122,605 $2.5m0.50% 0.50% UnchangedShares held: Q3 2024 2.1m, Q4 2024 2.1m, Q1 2025 2.1m, Q2 2025 2.1m
18 CANDEL THERAPEUTICS INC COM CADL CADL 405,837 $2.1m0.40% 0.40% UnchangedShares held: Q3 2024 405.8k, Q4 2024 405.8k, Q1 2025 405.8k, Q2 2025 405.8k
19 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 724,873 $1.7m0.33% 0.33% UnchangedShares held: Q3 2024 724.9k, Q4 2024 724.9k, Q1 2025 724.9k, Q2 2025 724.9k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
UIPATH INC PATH PATH 395,855 $4.1m395.9k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ACUMEN PHARMACEUTICALS INC ABOS · 13G · filed 2025-08-13 ABOS 5.6%≈ $9.1m 13G 2025-08-13